Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 4/20 | 0.41 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.41 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.41 |
| ▸ | NAT1 | P18440 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 4/20 | 0.33 |
| ▸ | CA12 | O43570 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | CDK4 | P11802 | 1/20 | 0.33 |
| ▸ | CCND1 | P24385 | 1/20 | 0.33 |
| ▸ | JUN | P05412 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11570965 | 0.79 | TNF (0.49) | NFKB1NPSR1MEN1ALDH1A1KMT2A | |
| SCHEMBL7159761 | 0.78 | MIF (0.42) | MIFTRIM24TRIM33NAT1MAPT | |
| SCHEMBL10616053 | 0.78 | MIF (0.42) | MIFTRIM24TRIM33NAT1MAPT | |
| SCHEMBL14760931 | 0.75 | MIF (0.40) | MIFTRIM24TRIM33NAT1MAPT | |
| SCHEMBL11350548 | 0.70 | MIF (0.36) | MIFTRIM24TRIM33NAT1MAPT | |
| SCHEMBL11347030 | 0.70 | MIF (0.36) | MIFTRIM24TRIM33NAT1MAPT | |
| SCHEMBL6959499 | 0.69 | — | — | |
| SCHEMBL8391117 | 0.68 | — | — | |
| SCHEMBL6961530 | 0.66 | KDM4E (0.31) | KDM4EMEN1KMT2A | |
| SCHEMBL6956541 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9504641-B2 | Therapy to reduce extravasation damage | PTLNV, LLC, SERIES 6 | 2016-11-29 | — | — | US | disclosed |
| US-20130064865-A1 | THERAPY TO REDUCE EXTRAVASATION DAMAGE | PTLNV, LLC, SERIES 6 | 2013-03-14 | — | — | US | disclosed |